recorlev
Generic: levoketoconazole
Labeler: xeris pharmaceuticals, inc.Drug Facts
Product Profile
Brand Name
recorlev
Generic Name
levoketoconazole
Labeler
xeris pharmaceuticals, inc.
Dosage Form
TABLET
Routes
Active Ingredients
levoketoconazole 150 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
72065-003
Product ID
72065-003_9e6fcf1e-f16d-4720-bb12-7e22b8a6d5c7
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA
Application Number
NDA214133
Listing Expiration
2026-12-31
Marketing Start
2021-12-30
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
72065003
Hyphenated Format
72065-003
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
recorlev (source: ndc)
Generic Name
levoketoconazole (source: ndc)
Application Number
NDA214133 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 150 mg/1
Packaging
- 50 TABLET in 1 BOTTLE (72065-003-01)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "9e6fcf1e-f16d-4720-bb12-7e22b8a6d5c7", "openfda": {"nui": ["N0000193935", "N0000193936", "N0000193984", "N0000182632", "N0000182141", "N0000185503", "N0000187061", "N0000191423", "N0000182139", "N0000187062"], "upc": ["0372065003013"], "unii": ["2DJ8R0NT7K"], "rxcui": ["2588848", "2588854"], "spl_set_id": ["d4c5fead-bc4a-fb02-e053-2a95a90ae4fc"], "pharm_class_epc": ["Cortisol Synthesis Inhibitor [EPC]"], "pharm_class_moa": ["Cytochrome P450 11B1 Inhibitors [MoA]", "Cytochrome P450 11A1 Inhibitors [MoA]", "Cytochrome P450 17A1 Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]", "Organic Cation Transporter 2 Inhibitors [MoA]", "Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]", "Cytochrome P450 2B6 Inhibitors [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]"], "manufacturer_name": ["Xeris Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "50 TABLET in 1 BOTTLE (72065-003-01)", "package_ndc": "72065-003-01", "marketing_start_date": "20211230"}], "brand_name": "Recorlev", "product_id": "72065-003_9e6fcf1e-f16d-4720-bb12-7e22b8a6d5c7", "dosage_form": "TABLET", "pharm_class": ["Cortisol Synthesis Inhibitor [EPC]", "Cytochrome P450 11A1 Inhibitors [MoA]", "Cytochrome P450 11B1 Inhibitors [MoA]", "Cytochrome P450 17A1 Inhibitors [MoA]", "Cytochrome P450 2B6 Inhibitors [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]", "Organic Cation Transporter 2 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "72065-003", "generic_name": "Levoketoconazole", "labeler_name": "Xeris Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Recorlev", "active_ingredients": [{"name": "LEVOKETOCONAZOLE", "strength": "150 mg/1"}], "application_number": "NDA214133", "marketing_category": "NDA", "marketing_start_date": "20211230", "listing_expiration_date": "20261231"}